相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study
Piero Barbanti et al.
HEADACHE (2021)
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Fabrizio Vernieri et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
Piero Barbanti et al.
HEADACHE (2021)
Monoclonal antibodies as a preventive therapy for migraine: A meta-analysis
Yousef Waleed Alasad et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
Wim M. Mulleners et al.
LANCET NEUROLOGY (2020)
Long-term safety, tolerability, and efficacy of fremanezumab in migraine A randomized study
Peter J. Goadsby et al.
NEUROLOGY (2020)
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study
David W. Dodick et al.
CEPHALALGIA (2019)
Current and emerging evidence-based treatment options in chronic migraine: a narrative review
Elio Clemente Agostoni et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Michel D. Ferrari et al.
LANCET (2019)
Preventive Treatment for Episodic Migraine
Simy K. Parikh et al.
NEUROLOGIC CLINICS (2019)
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial
David W. Dodick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Uwe Reuter et al.
LANCET (2018)
Fremanezumab for the Preventive Treatment of Chronic Migraine
Stephen D. Silberstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
Richard B. Lipton et al.
HEADACHE (2015)
Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view.
S. Saturni et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Eva Cernuda-Morollon et al.
NEUROLOGY (2013)
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine
Paul L. Durham et al.
CNS DRUGS (2010)
HIT-6 and MIDAS as Measures of Headache Disability in a Headache Referral Population
Khara M. Sauro et al.
HEADACHE (2010)
Migraine, allodynia, and implications for treatment
M. Schuerks et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
分享论文
